Identification of BRD4 as a Key Regulator of Cardiomyocyte Differentiation through Genome-wide CRISPR Screen – Insights from Nature Cardiovascular Research...
Repotrectinib, a promising targeted therapy, has shown significant tumor reduction in patients with ROS1-positive non-small cell lung cancer (NSCLC). This...
The role of S100A8/A9 in promoting endometrial fibrosis through the regulation of RAGE/JAK2/STAT3 signaling pathway – Insights from Communications Biology...
New Developments in NSCLC Treatment: Strategies to Overcome Osimertinib Resistance Non-small cell lung cancer (NSCLC) is the most common type...
Open Enrollment Begins for Phase 1b/2 Study Assessing Ampligen and Imfinzi Combination for Pancreatic Cancer Treatment Pancreatic cancer is one...
Merck Initiates Crucial Phase III Trials for New Drugs Targeting Oncologic and Hematologic Malignancies Merck, a leading pharmaceutical company, has...
The Food and Drug Administration (FDA) has recently approved the use of Xtandi (enzalutamide) for the treatment of high-risk prostate...
Revumenib by Syndax Demonstrates Effectiveness in Relapsed/Refractory KMT2A-Rearranged Acute Leukemia: ASH 2023 Findings Acute leukemia is a devastating blood cancer...
Title: ASH 2023 Study Reveals Improved Progression-Free Survival in Relapsed/Refractory Mantle Cell Lymphoma with the Addition of Venclexta to Imbruvica...
Alfasigma SpA, an Italian pharmaceutical company, and Galapagos NV, a Belgian biotechnology company, have recently announced a significant collaboration agreement...
Successful Pivotal Study Demonstrates Efficacy of Cytokinetics’ Heart Drug Aficamten Cytokinetics, a biopharmaceutical company focused on developing innovative treatments for...
Enhancing Titanium Rods Osseointegration in Osteoporotic Rats: The Role of Trichostatin A in Inhibiting Oxidative Stress via the AKT/Nrf2 Pathway...
Potential Discontinuation of BMS’ Opdivo and Yervoy Combination Raises Concerns for the Future of LAG-3 Inhibitors in Colorectal Cancer Colorectal...
New Findings: ACE2-dependent Susceptibility and Differentiation Impairment in Syncytiotrophoblasts Revealed by a Placental Model of SARS-CoV-2 Infection The ongoing COVID-19...
Title: Promising Results from ORSERDU® Combination Studies Presented at the 2023 San Antonio Breast Cancer Symposium Introduction: The 2023 San...
